Abstract: The present invention is concerned with compounds, medicaments and treatments for Clostridium difficile infection, together with novel isolated antibodies and their use in same. The present invention is also concerned with the treatment and prophylaxis of E. faecium and E. faecalis infection and provides medicaments and treatments for same.
Type:
Grant
Filed:
July 1, 2005
Date of Patent:
October 27, 2009
Assignee:
NeuTec Pharma Ltd.
Inventors:
James Peter Burnie, Ruth Christine Matthews, Tracey Carter